基础医学与临床 ›› 2015, Vol. 35 ›› Issue (3): 313-317.

• 研究论文 • 上一篇    下一篇

血管生成素及其突变体与核糖核酸酶抑制因子蛋白的相互作用

刘玉林1,庄翔1,陈俊霞2   

  1. 1. 重庆医科大学基础医学院
    2. 重庆医科大学
  • 收稿日期:2014-10-23 修回日期:2014-12-01 出版日期:2015-03-05 发布日期:2015-03-03
  • 通讯作者: 陈俊霞 E-mail:925760900@qq.com
  • 基金资助:
    衰老调控因子SIRT6与NF-κB对话在人参皂苷Rg1延缓造血干/祖细胞衰老中的作用

Ribonuclease inhibitor interacts with angiogenin and its mutant

  • Received:2014-10-23 Revised:2014-12-01 Online:2015-03-05 Published:2015-03-03

摘要: 目的 研究血管生成素(ANG)突变体与核糖核酸酶抑制因子(RI)的相互作用。方法 构建pCMV-3×flag-ANGH13R和pCMV-3×flag-ANGH114R突变体质粒;用免疫荧光标记结合共聚焦显微镜技术来确立RI与ANG突变体蛋白在BIU-87细胞内的定位;用GST融合蛋白沉降技术检测RI与ANG突变体蛋白在细胞外的相互作用;用免疫共沉淀(Co-IP)实验检测两蛋白在人膀胱癌BIU-87细胞内的相互作用。结果 pCMV-3×flag-ANGH13R和pCMV-3×flag-ANGH114R突变体质粒构建成功; RI和ANG突变体蛋白存在共定位现象;GST-RI融合蛋白诱导表达正确, RI和ANG突变体蛋白在原核反应体系中存在相互作用; RI与ANG突变体蛋白在真核细胞内存在相互作用。 结论 RI和ANG突变体蛋白在原核反应体系和真核细胞中都存在相互作用,并且两突变型与RI相互作用存在一定的差异。

关键词: 血管生成素突变体, 核糖核酸酶抑制因子, BIU-87细胞, 相互作用

Abstract: Objective TO research the protein-protein interaction between ribonuclease inhibitor(RI) a?nd angiogenin(ANG) mutant. Methods Construct pCMV-3×flag-ANGH13R and pCMV-3×flag-ANGH114R pl?asmid.Immunofluorescence assay and laser scanning confocal microscopy analysis were used to observe the co-localization between RI and ANG mutant in BIU-87 cells.The interaction between RI and ANG mutant in BIU-87 cells was identified by glutathione-S-transferase (GST) pull-down assay and co-immunoprecipitation assay. Results The expressing plasmid pCMV-3×flag-ANGH13Rand pCMV-3×flag-ANGH114Rwas verified by restriction enzyme digestion and DNA sequencing.We found that RI was coloc-alized with ANG mutant in BIU-87 cell by laser scanning confocal microscopy analysis.Prokaryotically expressed products were purified and their sequences were confirmed.Glutathione-S-transferase(GST) pull do?w?n and co-immunoprecipitation results showed that the interaction between RI and ANG mutant occur?r?ed in BIU-87 cells. Conclusion The interaction between RI and ANG occurs in BIU-87 cells. The difference between RI and ANG mutant exists in BIU-87 cells.

Key words: angiogenin mutant, ribonuclease inhibitor, BIU-87 cell, interaction